Albert Seymour - 09 Jan 2023 Form 4/A - Amendment Insider Report for Homology Medicines, Inc. (FIXX)

Role
President and Chief Executive Officer, Director
Signature
/s/ Paul Alloway, Attorney-in-Fact for Albert Seymour
Issuer symbol
FIXX
Transactions as of
09 Jan 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
20 Jan 2023, 15:05:13 UTC
Date Of Original Report
11 Jan 2023
Previous filing
04 Jan 2023
Next filing
27 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FIXX Common Stock 147,702 09 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amended Form 4 is being filed to correct the aggregate common stock holdings of the Reporting Person. The common stock holdings in column 5 of Table I have been increased by 4,536 shares acquired under the Issuer's Employee Stock Purchase Plan on dates ranging from February 28, 2019 to August 31, 2021, which were previously inadvertently omitted.

Remarks:

President and Chief Executive Officer